tert-Butyl 3-(2-ethoxy-2-oxoethyl)-3-methylazetidine-1-carboxylate

Catalog No. :
ACCKNY084
CAS No. :
2641906-15-0
Molecular Formula :
C13H23NO4
Molecular Weight :
257.33

IUPAC Name:tert-butyl 3-(2-ethoxy-2-oxoethyl)-3-methylazetidine-1-carboxylate

tert-Butyl 3-(2-ethoxy-2-oxoethyl)-3-methylazetidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$226.00Login to see priceIn stockInquiry
250mg95%$377.00Login to see priceIn stockInquiry
500mg95%$529.00Login to see priceIn stockInquiry
1g95%$755.00Login to see priceIn stockInquiry
5g95%$2264.00Login to see priceIn stockInquiry
10g95%$3773.00Login to see priceIn stockInquiry
25g95%$7545.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-(2-ethoxy-2-oxoethyl)-3-methylazetidine-1-carboxylate
IUPAC Nametert-butyl 3-(2-ethoxy-2-oxoethyl)-3-methylazetidine-1-carboxylate
Molecular FormulaC13H23NO4
Molecular Weight257.33
SMILESO=C(N1CC(C)(CC(OCC)=O)C1)OC(C)(C)C
InChI KeyPRCPNRFROCZYPG-UHFFFAOYSA-N
SynonymEthyl 1-[(1,1-dimethylethoxy)carbonyl]-3-methyl-3-azetidineacetate;tert-butyl 3-(2-ethoxy-2-oxoethyl)-3-methylazetidine-1-carboxylate;tert-butyl 3-(2-ethoxy-2-oxo-ethyl)-3-methyl-azetidine-1-carboxylate - [B86042]
CAS No.2641906-15-0

Synthetic Route by SureRoute

1. ACCKNY084 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCKNY084 route product structure diagram
    ACCKNY0842641906-15-0 In Stock
Inquiry

2. ACCKNY084 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGQNI659 route compound structure diagram
    ACGQNI6591002355-96-5 In Stock
  2. Then
  3. ACCKNY084 route product structure diagram
    ACCKNY0842641906-15-0 In Stock
Inquiry

Comments (0)